≡

Multiplex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) ,etc. by FLIA (Flow Luminescence Immunoassay)

Trem2a; Trem2b; Trem2c; Triggering receptor expressed on monocytes 2

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Triggering Receptor Expressed On Myeloid Cells 2 (TREM2).
No significant cross-reactivity or interference between Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) and the recovery rates were calculated by comparing the measured value to the expected amount of Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 89-96 93
EDTA plasma(n=5) 78-102 91
heparin plasma(n=5) 83-95 88

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-101% 88-102% 95-104% 88-97%
EDTA plasma(n=5) 86-96% 97-105% 80-103% 83-97%
heparin plasma(n=5) 78-89% 93-101% 79-101% 87-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:TREM2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Mult Scler Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone content:1352458515624558.abstract
Hum Brain Mapp Deep transfer learning of structural magnetic resonance imaging fused with blood parameters improves brain age prediction 34913545
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPG628Ra02 Recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Positive Control; Immunogen; SDS-PAGE; WB.
RPG628Ra03 Recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Positive Control; Immunogen; SDS-PAGE; WB.
RPG628Ra04 Recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Positive Control; Immunogen; SDS-PAGE; WB.
RPG628Ra01 Recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Positive Control; Immunogen; SDS-PAGE; WB.
RPG628Ra05 Recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Positive Control; Immunogen; SDS-PAGE; WB.
RPG628Ra06 Recombinant Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Positive Control; Immunogen; SDS-PAGE; WB.
PAG628Ra01 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) WB; IHC
LAG628Ra71 Biotin-Linked Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) WB; IHC; ICC.
SEG628Ra ELISA Kit for Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMG628Ra Multiplex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMG628Ra Multiplex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.